Jennifer Boggs

EntreMed Boosting Cancer Work With $30M Placement

Feb. 6, 2006

BioCryst, Mundipharma Enter Deal Potentially Worth $190M

Feb. 3, 2006

BioCryst Pharmaceuticals Inc. is expanding development and marketing for its lead product, Fodosine, through a potential $190 million oncology deal with Mundipharma International Holdings Ltd. (BioWorld Today)

BioCryst, Mundipharma Enter Deal Potentially Worth $190M

Feb. 3, 2006

By Jennifer Boggs

BioCryst Pharmaceuticals Inc. is expanding development and marketing for its lead product, Fodosine, through a potential $190 million oncology deal with Mundipharma International Holdings Ltd. (BioWorld Today)

Nastech's PTH Nasal Spray Lands $577M P&G Deal

Feb. 2, 2006

By Jennifer Boggs

Shares of Nastech Pharmaceutical Co. Inc. jumped 18 percent Wednesday on news of a potential $577 million deal with Procter & Gamble Pharmaceuticals Inc. to develop Nastech's nasal spray for osteoporosis. (BioWorld Today)

Nastech's PTH Nasal Spray Lands $577M P&G Deal

Feb. 2, 2006

By Jennifer Boggs

Shares of Nastech Pharmaceutical Co. Inc. jumped 18 percent Wednesday on news of a potential $577 million deal with Procter & Gamble Pharmaceuticals Inc. to develop Nastech's nasal spray for osteoporosis. (BioWorld Today)